← Search & browse all drugs
RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › ADRENERGICS, INHALANTS › Selective beta-2-adrenoreceptor agonists
reproterol
R03AC15
Forms & Strengths
- Inhalation solution: 0.9%
- Metered-dose inhaler: 0.5 mg/puff
- Tablet: 20 mg
- Syrup: 1 mg/mL
Adult Dosing
- Inhalation: 1-2 puffs (0.5-1 mg) up to 4 times daily
- Oral: 20 mg 3 times daily
- Intravenous (acute bronchospasm): 0.09-0.18 mg slowly over 3-5 minutes
Pediatric Dosing
- Children > 6 years (Inhalation): 1 puff up to 4 times daily
- Children 6-12 years (Oral): 10 mg 2-3 times daily
- Children > 12 years (Oral): 20 mg 3 times daily
Indications
- Bronchial asthma
- Chronic obstructive pulmonary disease (COPD) with reversible airway obstruction
- Acute bronchospasm
Mechanism of Action
- Selective beta-2 adrenergic receptor agonist
- Stimulates intracellular adenylate cyclase, increasing cyclic AMP
- Relaxes bronchial smooth muscle and inhibits release of immediate hypersensitivity mediators
Contraindications
- Hypersensitivity to reproterol or other sympathomimetics
- Hypertrophic obstructive cardiomyopathy (HOCM)
- Pheochromocytoma
- Tachyarrhythmias
Adverse Reactions
- Fine tremors (especially of the hands)
- Palpitations and tachycardia
- Muscle cramps
- Nervousness or restlessness
- Hypokalemia at high doses
Drug Interactions
- Non-selective beta-blockers antagonize the bronchodilatory effect
- Other sympathomimetic agents increase cardiovascular side effects
- Xanthine derivatives, corticosteroids, and diuretics may potentiate hypokalemia
- Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants enhance cardiovascular toxicity
Curated Content: Needs Vetting Before Put to Clinical Use